I am a Postdoctoral researcher in the Biotechnology unit at the Department of Life Technologies. My current research is on clinical biomarkers and epidemiological studies in lung cancer. 

I have extensive experience in immunoassay development and optimization, along with verification and clinical validation studies. I have also done extensive data analysis and am experienced with using R programming, SPSS, Origin, JMP. I also have some knowledge regarding regulatory considerations. 

Cancer is largely asymptomatic in early stages and the mortality increases with late detection. I look at glycosylation changes in cancer to identify new biomarkers that can be used as diagnostic targets. We have a highly sensitive and fluorescent nanoparticle based technology that we use to develop diagnostic assays for early cancer detection. I have developed an ovarian cancer diagnostic test that shows improved performance in postmenopausal women and in early stage cases compared to conventional assays. This test is now in the commercialization phase with a local diagnostic Turku based company. My current research as a postdoc includes identifying novel biomarkers for lung cancer diagnosis, that we are now in the process of patenting.